Project

ETOP 15-19 ABC Lung A randomised non-comparative open label phase II trial of atezolizumab plus bevacizumab, with carboplatin-paclitaxel or pemetrexed, in EGFR-mutant non-small cell lung carci-noma with acquired resistance ABC-lung:

Ongoing - recruitment active · 2020 until 2025